Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older at the time of joining the trial
- People who have received a heart transplant within the past month (within a window of roughly 2 weeks either side)
- People whose follow-up care is planned to continue at the transplant centre for at least one year
- People who are able and willing to attend all required study visits and follow the study procedures
Who may not be able to join:
- People who received more than one organ transplant at the same time (for example, a heart and kidney together)
- People who had a previous solid organ transplant (such as a kidney, liver, or lung) before their current heart transplant
- People who are currently on mechanical heart support devices or whose heart and circulation are not stable (for example, those still needing medications to support blood pressure or heart function)
- People who currently need kidney dialysis or another form of kidney replacement therapy
- People who have an active infection that requires a hospital stay, antibiotic or antifungal treatment, or a reduction in their anti-rejection medications
- People whose body is actively rejecting the transplanted heart and who are being treated with intravenous medications or a blood-filtering procedure called plasmapheresis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Palak Shah, MD, Inova Schar Heart and Vascular
Phone: (703) 776-8000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time-to-Event Analysis of Circulating microRNAs (miRs) Predicting Infection in Pediatric Heart Transplant Recipients; Time-to-Event Analysis of Circulating microRNAs (miRs) Predicting Rejection in Pediatric Heart Transplant Recipients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.